Edgewise Therapeutics Inc (NASDAQ:EWTX)’s traded shares stood at 0.54 million during the last session, with the company’s beta value hitting 0.24. At the close of trading, the stock’s price was $15.23, to imply a decrease of -1.42% or -$0.22 in intraday trading. The EWTX share’s 52-week high remains $20.69, putting it -35.85% down since that peak but still an impressive 66.38% since price per share fell to its 52-week low of $5.12. The company has a valuation of $1.42B, with an average of 935.03K shares over the past 3 months.

Edgewise Therapeutics Inc (NASDAQ:EWTX) trade information

After registering a -1.42% downside in the last session, Edgewise Therapeutics Inc (EWTX) has traded red over the past five days. The stock hit a weekly high of 16.99, dropping -1.42% in its intraday price action. The 5-day price performance for the stock is -6.96%, and -9.18% over 30 days. With these gigs, the year-to-date price performance is 39.21%.

Edgewise Therapeutics Inc (EWTX) estimates and forecasts

Looking at statistics comparing Edgewise Therapeutics Inc share performance against respective industry, we note that the company has underperformed competitors. Edgewise Therapeutics Inc (EWTX) shares are 110.94% up over the last 6 months, with its year-to-date growth rate lower than industry average at -12.10% against 13.30%.

EWTX Dividends

Edgewise Therapeutics Inc has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Edgewise Therapeutics Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.